<DOC>
	<DOCNO>NCT01199419</DOCNO>
	<brief_summary>The objective present study analyze cost-effectiveness percutaneous coronary intervention ( PCI ) use TAXUS stent compare cost coronary artery bypass surgery ( CABG ) patient multivessel coronary artery disease ( CAD ) first 5 year 10 year intervention . Multivessel PCI CABG perform 114 93 patient , respectively . Clinical outcome , term incidence acute myocardial infarction ( AMI ) , all-cause death , target vessel revascularization ( TVR ) stroke , resource use cost analyze prospectively 5 10-year follow-up ( FUP ) period . Overall cost consist baseline cost index procedure ( PCI CABG ) , clinical angiographic procedure-related treatment entire FUP . The primary endpoint cost-effectiveness clinical effectiveness , define reduction composite major adverse cardiac cerebrovascular event ( MACCE ) .</brief_summary>
	<brief_title>Cost-effectiveness PCI With Taxus v CABG - 5 Years FUP</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>two threevessel disease require percutaneous surgical multivessel intervention aim complete revascularization age &gt; 18 year clinical symptom ( stable unstable angina ) sign myocardial ischemia â‰¥ 50 % diameter stenosis lesion acute myocardial infarction ( &lt; 48 h ) ; contraindication clopidogrel , aspirin , heparin taxol ; pregnancy lack protection pregnancy breastfeed study ; hemorrhagic diathesis platelet count &lt; 100.000/ml3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>multivessel coronary artery disease</keyword>
	<keyword>drug-eluting stent</keyword>
	<keyword>CABG</keyword>
	<keyword>cost-effectiveness</keyword>
</DOC>